Enanta Pharmaceuticals
ENTA
#7360
Rank
HK$3.45 B
Marketcap
HK$119.75
Share price
5.92%
Change (1 day)
145.32%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total assets

Total assets on the balance sheet as of September 2025 : HK$2.18 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are HK$2.18 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-09-30HK$2.92 B-19.12%
2023-09-30HK$3.62 B22.84%
2022-09-30HK$2.94 B-13.74%
2021-09-30HK$3.41 B-9.32%
2020-09-30HK$3.76 B-1.87%
2019-09-30HK$3.83 B18.4%
2018-09-30HK$3.24 B27.11%
2017-09-30HK$2.55 B16.93%
2016-09-30HK$2.18 B14.43%
2015-09-30HK$1.90 B57.99%
2014-09-30HK$1.20 B33.02%
2013-09-30HK$0.90 B124.31%
2012-09-30HK$0.40 B98.93%
2011-09-30HK$0.20 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AbbVie
ABBV
HK$1.041 T 47,596.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$1.500 T 68,583.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$193.44 B 8,756.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$1.007 T 46,045.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$753.87 B 34,412.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$834.79 B 38,117.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland